Fig 2.

ARID5B single nucleotide polymorphisms are associated (CC, CT, and TT) with both acute lymphoblastic leukemia (ALL) susceptibility and relapse. (A) Relationship between genotype at ARID5B single nucleotide polymorphism rs6479778 and ALL relapse in the Children's Oncology Group P9904/9905 clinical trials. P value was determined by Fine and Gray's regression model after adjusting for treatment arm and ancestry. (B) Allele T at rs6479778 was more frequent in ALL cases than in controls and more common in Hispanics than in whites. P values were estimated by logistic regression.